Results 151 to 160 of about 117,026 (248)

Small Bowel Lesions and Bleeding Risk in Hemodialysis Patients: A Narrative Review

open access: yesHemodialysis International, Volume 30, Issue 4, Page 665-678, October 2026.
ABSTRACT Background Gastrointestinal bleeding is very common among hemodialysis patients. This high bleeding risk is caused by uremic platelet dysfunction, vascular fragility, intradialytic hemodynamic instability, and widespread antithrombotic therapy.
Andreas Smyrlis   +3 more
wiley   +1 more source

Controversies in NEN: An ENETS position statement on the role of liver transplantation (LT) in patients with advanced small‐intestinal and pancreatic NETs

open access: yesJournal of Neuroendocrinology, Volume 38, Issue 10, October 2026.
Abstract Liver transplantation (LT) may offer survival or symptomatic benefit for highly selected patients with advanced, well‐differentiated small‐intestinal or pancreatic neuroendocrine tumours and unresectable liver‐dominant metastases. However, its role remains controversial, as LT is rarely curative, recurrence is common, and benefits must be ...
Peter Stålberg   +11 more
wiley   +1 more source

Types of Neurons in the Myenteric Plexus of Human Gastric Corpus Identified by Multi‐Layer Immunohistochemical Coding and Vagal Tracing

open access: yesNeurogastroenterology &Motility, Volume 38, Issue 10, October 2026.
Myenteric nerve cell bodies in the human gastric corpus were divided into 12 classes by the combinatorial expression of 15 neuronal markers, using multiplexed immunohistochemistry (1084 neurons from 7 individuals). Baskets of axonal varicosities from vagal or enteric sources were analyzed to detect targeted patterns of connectivity ...
M. E. Johnson   +10 more
wiley   +1 more source

Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki-67 Is ≥10%? [PDF]

open access: yesOncologist, 2021
Merola E   +16 more
europepmc   +1 more source

Beyond Tumor Control in Sporadic Neuroendocrine Tumor: Metabolic and Bone Health During Treatment with Somatostatin Analogs. [PDF]

open access: yesJ Clin Med
Modica R   +7 more
europepmc   +1 more source

Somatostatin analogs in neuroendocrine tumors with Ki-67 index of ≥10. [PDF]

open access: yesJ Neuroendocrinol
Braegelmann J   +6 more
europepmc   +1 more source

Outcome of Patients With Metastatic Lung Neuroendocrine Tumors Submitted to First Line Monotherapy With Somatostatin Analogs. [PDF]

open access: yesFront Endocrinol (Lausanne), 2021
Lenotti E   +9 more
europepmc   +1 more source

Somatostatin Analogs Versus Active Surveillance in Small Pancreatic Neuroendocrine Tumors. [PDF]

open access: yesPancreas
Maratta MG   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy